Search - tctmd.com

Displaying 621 - 640 of 809

Sort: Relevancy | Date

Presentation TVT 2017

MitraClip for TR: Technique and Outcomes

Presenter: Joachim Schofer, Maurizio Taramasso

June 16, 2017

Presentation TVT 2017

Tricuspid Valve-in-Valve

Presenter: Joachim Schofer, Chet Rihal

June 16, 2017

Presentation TVT 2017

ECHO Imaging for Tricuspid Valve Interventions

Presenter: Joachim Schofer, Omar K. Khalique

June 16, 2017

Presentation TVT 2017

Technique and Outcomes of Surgery for Tricuspid Regurgitation

Presenter: Robert L. Smith, Mark J. Russo

June 16, 2017

Presentation TVT 2017

ECHO Assessment of TR Severity and Relationship to Prognosis and Interventional Management

Presenter: Robert L. Smith, Omar K. Khalique

June 16, 2017

Presentation TVT 2017

Tricuspid Regurgitation: Etiology, Pathophysiology, and Scope of the Problem

Presenter: Robert L. Smith, Adam B. Greenbaum

June 16, 2017

Presentation TVT 2017

Tricuspid Anatomy 101

Presenter: Robert L. Smith

June 16, 2017

Presentation TVT 2017

Are Cardiac CT and MRI Necessary to Assess TR Structure or Severity?

Presenter: Robert L. Smith, João L Cavalcante

June 16, 2017

Presentation TVT 2017

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Presenter: David J. Cohen, Mark J. Russo, Adam Castano

June 16, 2017

Presentation TVT 2017

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Presenter: David J. Cohen, Mark J. Russo, Nir Uriel

June 16, 2017

Presentation TVT 2017

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Presenter: David J. Cohen, Mark J. Russo, Ran Kornowski

June 16, 2017

Presentation TVT 2017

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Presenter: David J. Cohen, Mark J. Russo, Suzanne V. Arnold

June 16, 2017

Presentation TVT 2017

Ineffective Endocarditis After TAVR: Cause for Concern?

Presenter: David J. Cohen, Mark J. Russo, Bernard Prendergast

June 16, 2017

Presentation TVT 2017

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

Presenter: David J. Cohen, Mark J. Russo, Molly Szerlip

June 16, 2017

Presentation TVT 2017

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Presenter: Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Presenter: Raj Makkar

June 16, 2017

Presentation TVT 2017

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

Presenter: Jean-Michel Paradis

June 16, 2017

Presentation TVT 2017

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

Presenter: Brij Maini

June 16, 2017

Presentation TVT 2017

Frequency and Clinical Management Issues in TAVR Patients

Presenter: John G. Webb

June 16, 2017

Advertisement

MitraClip for TR: Technique and Outcomes

Tricuspid Valve-in-Valve

ECHO Imaging for Tricuspid Valve Interventions

Technique and Outcomes of Surgery for Tricuspid Regurgitation

ECHO Assessment of TR Severity and Relationship to Prognosis and Interventional Management

Tricuspid Regurgitation: Etiology, Pathophysiology, and Scope of the Problem

Tricuspid Anatomy 101

Are Cardiac CT and MRI Necessary to Assess TR Structure or Severity?

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Ineffective Endocarditis After TAVR: Cause for Concern?

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

Frequency and Clinical Management Issues in TAVR Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content